BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17344302)

  • 41. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
    Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
    J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
    Bansal A; Gough E; Sabbaj S; Ritter D; Yusim K; Sfakianos G; Aldrovandi G; Kaslow RA; Wilson CM; Mulligan MJ; Kilby JM; Goepfert PA
    AIDS; 2005 Feb; 19(3):241-50. PubMed ID: 15718834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children.
    Scott-Algara D; Buseyne F; Porrot F; Corre B; Bellal N; Rouzioux C; Blanche S; Riviere Y
    J Clin Immunol; 2005 Jan; 25(1):57-67. PubMed ID: 15742158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
    Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
    J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
    D'Offizi G; Gioia C; Corpolongo A; Martini F; Paganelli R; Volpi I; Sacchi A; Tozzi V; Narciso P; Poccia F
    Int J Immunopathol Pharmacol; 2007; 20(3):473-85. PubMed ID: 17880761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
    Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
    Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human immunodeficiency virus gag and pol-specific CD8 T cells in perinatal HIV infection.
    McCloskey TW; Haridas V; Pahwa R; Pahwa S
    Cytometry; 2001 Oct; 46(5):265-70. PubMed ID: 11746101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15.
    Chitnis V; Pahwa R; Pahwa S
    Clin Immunol; 2003 Apr; 107(1):36-45. PubMed ID: 12738248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
    J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.
    Paiardini M; Cervasi B; Albrecht H; Muthukumar A; Dunham R; Gordon S; Radziewicz H; Piedimonte G; Magnani M; Montroni M; Kaech SM; Weintrob A; Altman JD; Sodora DL; Feinberg MB; Silvestri G
    J Immunol; 2005 Mar; 174(5):2900-9. PubMed ID: 15728501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
    Shankar P; Russo M; Harnisch B; Patterson M; Skolnik P; Lieberman J
    Blood; 2000 Nov; 96(9):3094-101. PubMed ID: 11049989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection.
    Radebe M; Nair K; Chonco F; Bishop K; Wright JK; van der Stok M; Bassett IV; Mncube Z; Altfeld M; Walker BD; Ndung'u T
    J Infect Dis; 2011 Sep; 204(5):768-76. PubMed ID: 21844303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.
    Kaul R; Plummer FA; Kimani J; Dong T; Kiama P; Rostron T; Njagi E; MacDonald KS; Bwayo JJ; McMichael AJ; Rowland-Jones SL
    J Immunol; 2000 Feb; 164(3):1602-11. PubMed ID: 10640781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.
    Malhotra U; Holte S; Zhu T; Delpit E; Huntsberry C; Sette A; Shankarappa R; Maenza J; Corey L; McElrath MJ
    J Virol; 2003 Feb; 77(4):2663-74. PubMed ID: 12552005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.
    Kuebler PJ; Mehrotra ML; McConnell JJ; Holditch SJ; Shaw BI; Tarosso LF; Leadabrand KS; Milush JM; York VA; Raposo RA; Cheng RG; Eriksson EM; McMahan V; Glidden DV; Shiboski S; Grant RM; Nixon DF; Kallás EG
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8379-84. PubMed ID: 26100867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
    Quinn KM; Da Costa A; Yamamoto A; Berry D; Lindsay RW; Darrah PA; Wang L; Cheng C; Kong WP; Gall JG; Nicosia A; Folgori A; Colloca S; Cortese R; Gostick E; Price DA; Gomez CE; Esteban M; Wyatt LS; Moss B; Morgan C; Roederer M; Bailer RT; Nabel GJ; Koup RA; Seder RA
    J Immunol; 2013 Mar; 190(6):2720-35. PubMed ID: 23390298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans.
    Currier JR; Dowling WE; Wasunna KM; Alam U; Mason CJ; Robb ML; Carr JK; McCutchan FE; Birx DL; Cox JH
    AIDS; 2003 Oct; 17(15):2149-57. PubMed ID: 14523271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.